resulting in different types of amyloidosis with different symptoms. These proteins can build up in the blood vessels, bones, and major organs, leading to various complications. One of the most ...

Early clinical diagnosis of an under-recognized form of amyloidosis that causes rapidly progressing polyneuropathy is crucial to improving patient outcomes. Worldwide, the most common mutation ...

Patients with cardiac amyloidosis have very poor survival without therapy. Diagnosis at early stages of the disease is crucial and there are many diagnostic tools for cardiac amyloidosis.

Cardiac amyloidosis is a myocardial disease characterized by extracellular amyloid infiltration throughout the heart. Cardiac amyloidosis has a wide spectrum of clinical manifestations but the ...

At our Cardiac Amyloidosis Clinic, people with a diagnosis of cardiac amyloidosis receive treatment from a team of experts. If you have related symptoms such as swelling of the ankles and legs ...

Ultromics Ltd. received clearance from the U.S. FDA for Echogo Amyloidosis, its artificial intelligence-enhanced software ...

Specific causes depend on the type of amyloidosis. Symptoms show up at an advanced stage of the condition, depending on the type of amyloidosis. Early diagnosis can control damage to organs ...

Alnylam Pharmaceuticals ALNY announced that the FDA has accepted its supplemental new drug application (sNDA) seeking the ...

The stock market responded positively to the company's announcement, with its share price leaping more than 28% following the ...

Ultromics' EchoGo® Amyloidosis, clinical AI for echocardiography with the potential to revolutionize early detection of ...

The approval of Attruby for transthyretin amyloidosis with cardiomyopathy begins a battle for control of a lucrative market ...